Lumentum, Woodward, And Teradyne Are Among the Top 10 Large-Cap Gainers Last Week (Feb. 2-Feb. 6): Are the Others in Your Portfolio?
Nabaparna Bhattacharya 8 months ago
EquitiesNewsMarketsMoversGeneral
Last week's top large-cap gainers surged on strong earnings beats and upbeat guidance (LITE, XPO, RRX, WWD, TPR), analyst upgrades (TER), oil-linked transport tailwinds (SAIA), and major catalysts like positive trial data (ROIV) and a new U.S. Army contract (OSK).
These ten large-cap stocks were top performers last week. Are they a part of your portfolio?
Lumentum Holdings Inc. (NASDAQ:LITE) gained 36.02% this week after the company reported better-than-expected second-quarter financial results and issued third-quarter guidance above estimates. Also, multiple firms raised their respective price targets on the stock.
XPO, Inc. (NYSE:XPO) increased 37.75% this week after the company reported better-than-expected fourth-quarter financial results. Also, multiple firms raised their respective price targets on the stock.
Regal Rexnord (NYSE:RRX) soared 32.14% this week after the company reported better-than-expected fourth-quarter adjusted EPS results. Also, multiple firms raised their respective price targets on the stock.
Teradyne, Inc. (NASDAQ:TER) gained 23.66% this week after multiple analysts raised their price forecast on the stock.
Saia, Inc. (NASDAQ:SAIA) jumped 23.07% this week. Shares of transportation companies gained ground amid declining oil prices.
Woodward, Inc. (NASDAQ:WWD) rose 22.38% this week after the company reported better-than-expected first quarter financial results and raised its FY26 guidance above estimates. Also, multiple firms raised their respective price targets on the stock.
Westlake Corporation (NYSE:WLK) increased 19.27% this week.
Tapestry, Inc. (NYSE:TPR) jumped 20.26% this week after the company reported better-than-expected second-quarter financial results and raised its FY26 EPS guidance above estimates.
Roivant Sciences Ltd. (NASDAQ:ROIV) gained 19.70% this week on positive Phase 2 results for brepocitinib in cutaneous sarcoidosis (CS), an inflammatory skin condition with small bumps and broad, raised skin lesions. Stock also gained traction after the company reported better-than-expected third-quarter sales results.
Oshkosh Corporation (NYSE:OSK) increased 17.56% this week after it was awarded an additional $25 million contract from the U.S. Army to deliver FMTV A2 Low-Velocity Airdrop (LVAD) 4×4 Cargo vehicles and kits.